Bioprocessing White Papers

  1. Where Speed Meets Complexity In Bioprocess Development 6/18/2026

    Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

  2. Accelerating Biologics With Seamless Technology Transfer 6/17/2026

    Discover how effective technology transfer strategies can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.

  3. Effects Of Sequence Fidelity On Cloning Efficiency 6/15/2026

    dsDNA fragments speed up cloning but introduce variability that can affect results. Comparing fragment fidelity, efficiency, and design considerations helps researchers choose the right approach.

  4. Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs) 6/15/2026

    ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

  5. ADC Manufacturing: Practices, Challenges, And The Road Ahead 6/15/2026

    ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

  6. ADCs As Biological Missiles For Targeted Therapies 6/15/2026

    Antibody-drug conjugates are reshaping cancer treatment. Learn how monoclonal antibody targeting, linker design, and next-gen payloads are defining the future of precision oncology.

  7. Stabilizing Your Supply Chain In Times Of Global Volatility 6/12/2026

    Discover how a proactive, risk-based supply chain strategy can help strengthen resilience, mitigate disruption, and ensure continuity across your biotech and pharmaceutical operations.

  8. Where Innovation And Investment Reduce Drug Development Risk 6/12/2026

    How strategic investments in development, manufacturing, and clinical supply are helping organizations reduce risk and accelerate drug development.

  9. How To Maximize Pipeline Value And Enhance eNPV 6/9/2026

    Find out how reducing vendor fragmentation can improve program continuity, minimize delays, and support more predictable development outcomes.

  10. Avoiding The Pitfalls Of APQR 6/9/2026

    Traditional quality reviews often fall short in today’s data-heavy environment. A real-time, digital-first approach enables faster insights, stronger compliance, and more proactive quality management.